We are live on
!
Find out more
Creative Planning Portfolio holdings
AUM
$147B
1-Year Est. Return
18.73%
This Fund
S&P 500
This Quarter
Est. Return
-0.75%
1 Year Est. Return
+18.73%
3 Year Est. Return
+48.71%
5 Year Est. Return
+44.71%
10 Year Est. Return
+145.34%
AUM
$106B
AUM Growth
+$3.52B
(+3.4%)
Cap. Flow
+$5.21B
Cap. Flow
% of AUM
4.9%
Top 10 Holdings %
Top 10 Hldgs %
45.25%
Holding
3,801
New
219
Increased
2,152
Reduced
975
Closed
349
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR Portfolio Developed World ex-US ETF
SPDW
|
+$647M |
| 2 |
Vanguard Total Bond Market
BND
|
+$580M |
| 3 |
Avantis International Small Cap Value ETF
AVDV
|
+$328M |
| 4 |
Avantis US Small Cap Value ETF
AVUV
|
+$305M |
| 5 |
Dimensional US Small Cap ETF
DFAS
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$250M |
| 2 |
WisdomTree Emerging Markets SmallCap Dividend Fund
DGS
|
+$92.5M |
| 3 |
Vanguard Real Estate ETF
VNQ
|
+$61.7M |
| 4 |
Apple
AAPL
|
+$27.7M |
| 5 |
Vanguard Total Stock Market ETF
VTI
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.35% |
| 2 | Financials | 3.91% |
| 3 | Consumer Discretionary | 1.87% |
| 4 | Healthcare | 1.85% |
| 5 | Communication Services | 1.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3176
PUT
Maplebear
CART
$9.92B
| $141K | ﹤0.01% |
67,900
| – | – |
|
3177
Zymeworks
ZYME
$1.68B
| $141K | ﹤0.01% |
11,822
+11,765
| +20,640% | +$160K |
|
3178
Torrid Holdings
CURV
$247M
| $141K | ﹤0.01% |
25,650
+13,445
| +110% | +$80.5K |
|
3179
RUM Group Inc
RUM
$1.57B
| $140K | ﹤0.01% |
19,734
-1,185
| -6% | -$12.4K |
|
3180
Empire State Realty Series ES
ESBA
$1.47B
| $140K | ﹤0.01% |
17,977
| – | – |
|
3181
D-Wave Quantum
QBTS
$6B
| $139K | ﹤0.01% |
18,266
+4,413
| +32% | +$29.6K |
|
|
EHAB
3182
DELISTED
Enhabit
EHAB
| $138K | ﹤0.01% |
15,754
+1,372
| +10% | +$11.5K |
|
3183
Health Catalyst
HCAT
$154M
| $138K | ﹤0.01% |
30,551
+8,811
| +41% | +$46.6K |
|
3184
Xponential Fitness
XPOF
$265M
| $138K | ﹤0.01% |
16,580
+4,285
| +35% | +$59.7K |
|
|
AVDL
3185
DELISTED
Avadel Pharmaceuticals
AVDL
| $138K | ﹤0.01% |
17,617
+17,467
| +11,645% | +$146K |
|
3186
Aurinia Pharmaceuticals
AUPH
$1.97B
| $138K | ﹤0.01% |
17,105
+973
| +6% | +$7.88K |
|
3187
Grab
GRAB
$13.5B
| $137K | ﹤0.01% |
30,342
+1,806
| +6% | +$8.43K |
|
3188
iQIYI
IQ
$1.18B
| $135K | ﹤0.01% |
59,933
-145,713
| -71% | -$320K |
|
3189
Westrock Coffee
WEST
$741M
| $135K | ﹤0.01% |
18,706
-8,761
| -32% | -$57.4K |
|
3190
Funko
FNKO
$323M
| $135K | ﹤0.01% |
19,680
-2,438
| -11% | -$28.3K |
|
|
HOUS
3191
DELISTED
Anywhere Real Estate
HOUS
| $134K | ﹤0.01% |
40,129
-3,663
| -8% | -$13K |
|
3192
Mitek Systems
MITK
$762M
| $133K | ﹤0.01% |
16,063
-7,202
| -31% | -$70K |
|
3193
Prothena Corp
PRTA
$458M
| $132K | ﹤0.01% |
10,690
-5,371
| -33% | -$75.9K |
|
|
PFL
3194
PIMCO Income Strategy Fund
PFL
$381M
| $132K | ﹤0.01% |
15,373
| – | – |
|
3195
NeoGenomics
NEO
$1.81B
| $132K | ﹤0.01% |
13,895
-8,430
| -38% | -$105K |
|
|
NPKI
3196
NPK International
NPKI
$1.21B
| $131K | ﹤0.01% |
22,476
+5,046
| +29% | +$33.5K |
|
3197
Entrada Therapeutics
TRDA
$227M
| $131K | ﹤0.01% |
+14,443
| New | +$180K |
|
|
PBT
3198
Permian Basin Royalty Trust
PBT
$1.36B
| $130K | ﹤0.01% |
13,092
-98
| -0.7% | -$1.06K |
|
3199
Ocular Therapeutix
OCUL
$1.86B
| $129K | ﹤0.01% |
17,619
-1,084
| -6% | -$8.33K |
|
3200
Evolus
EOLS
$394M
| $129K | ﹤0.01% |
10,716
-3,017
| -22% | -$39.5K |
|
Similar funds
Creative Planning's Q1 2025 Portfolio in Review
As of Q1 2025, Creative Planning held 3,801 positions worth $106B, up 3.4% from $103B the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Creative Planning deployed $5.21B of net new capital in Q1 2025, opening 219 new positions and adding to 2,152 existing holdings. Its largest new stake was Fidelity Blue Chip Growth ETF: 1,157,513 shares worth $46.3M.
By sector, the portfolio is most concentrated in Technology at 6.3% of assets, down from 7.1% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $250M trimmed.
- Creative Planning's largest Q1 2025 buy was Fidelity Blue Chip Growth ETF: 1,157,513 shares worth $46.3M.
- Creative Planning added most to State Street SPDR Portfolio Developed World ex-US ETF in Q1 2025, an estimated $647M increase.
- Creative Planning's biggest Q1 2025 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $250M.
- Creative Planning fully exited Blue Owl Capital Corporation III in Q1 2025, selling an estimated $15.5M.
- Creative Planning's ten largest holdings make up 45% of its $106B portfolio in Q1 2025.
- Creative Planning opened 219 new positions and closed 349 in Q1 2025.
- Creative Planning's portfolio value rose 3.4% quarter-over-quarter to $106B.
Based on Creative Planning's 13F filing for Q1 2025, filed 15 May 2025.